Efficacy of Treatment for Somatoform Disorders: A Review of Randomized Controlled Trials
The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To review the evidence from randomized clinical trials (RCTs) that have focused on the treatment of patients with Diagnostic and Statistical Manual of Mental Disorders, 4(th) Edition (DSM-IV) somatoform disorders. Although somatoform disorders are among the most common mental disorders presenting in the general medical setting, the strength of evidence for specific treatments has not been well synthesized. METHODS: MEDLINE search of articles published in English from 1966 to 2006, using the following search terms: randomized clinical trial, somatoform disorders, somatization disorder, undifferentiated somatoform disorder, hypochrondriasis, conversion disorder, pain disorder, and body dysmorphic disorder. RESULTS: A total of 34 RCTs involving 3922 patients were included. Two thirds of the studies involved somatization disorder (n = 4 studies) and lower threshold variants, such as abridged somatization disorder (n = 9) and medically unexplained symptoms (n = 10). Cognitive behavioral therapy (CBT) was effective in most studies (11 of 13), as were antidepressants in a small number (4 of 5) of studies. RCTs examining a variety of other treatments showed benefit in half (8 of 16) of the studies, the most consistent evidence existing for a consultation letter to the primary care physician. Effective treatments have been established for all somatoform disorders except conversion disorder (1 of 3 studies showing benefit) and pain disorder (no studies reported). CONCLUSION: CBT is the best established treatment for a variety of somatoform disorders, with some benefit also demonstrated for a consultation letter to the primary care physician. Preliminary but not yet conclusive evidence exists for antidepressants.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The PHQ-15: Validity of a New Measure for Evaluating the Severity of Somatic Symptoms
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2002) · Psychosomatic Medicine · doi:10.1097/00006842-200203000-00008 · Cited by 3,298
Self-citationUtility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study
Spitzer, R. L. (1994) · JAMA · doi:10.1001/jama.272.22.1749 · Cited by 2,635
Effect Sizes for Interpreting Changes in Health Status
Kazis, L. E., Anderson, J. J., & Meenan, R. F. (1989) · Medical Care · doi:10.1097/00005650-198903001-00015 · Cited by 2,401 · cited 1×
“8 or greater are considered large therapeutic effects (61).”
BackgroundUtility of a New Procedure for Diagnosing Mental Disorders in Primary Care: The PRIME-MD 1000 Study
Spitzer, R. L. (1994) · JAMA · doi:10.1001/jama.1994.03520220043029 · Cited by 1,873
Summing up: The Science of Reviewing Research
Wilkinson, I., Light, R. J., & Pillemer, D. B. (1987) · Journal of Educational Statistics · doi:10.2307/1164691 · Cited by 1,471
Summing Up: The Science of Reviewing Research
Light, R. J., & Pillemer, D. B. (1984) · Harvard University Press eBooks · doi:10.4159/9780674040243 · Cited by 1,427
Barsky, A. J., Orav, E. J., & Bates, D. W. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.8.903 · Cited by 911
Medically Unexplained Physical Symptoms, Anxiety, and Depression: A Meta-Analytic Review
Henningsen, P., Zimmermann, T., & Sattel, H. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000075977.90337.e7 · Cited by 829
Ormel, E. A. (1995) · PsycEXTRA Dataset · doi:10.1037/e536912011-072 · Cited by 706
Patients presenting with somatic complaints: epidemiology, psychiatric co‐morbidity and management
Kroenke, K. (2003) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.140 · Cited by 624
Self-citationLin, E. H. B., Katon, W., Von Korff, M., Tang, L., Williams, Jr., Kroenke, K., Hunkeler, E., Harpole, L., Hegel, M., Arean, P., et al. (2003) · JAMA · doi:10.1001/jama.290.18.2428 · Cited by 590
Self-citationDe Waal, M. W. M., Arnold, I. A., Eekhof, J. A. H., & Van Hemert, A. M. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.6.470 · Cited by 533
Somatoform Disorders: Time for a New Approach in DSM-V
Mayou, R., Kirmayer, L. J., Simon, G., Kroenke, K., & Sharpe, M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.5.847 · Cited by 480
Self-citationKroenke, K., & Swindle, R. (2000) · Psychotherapy and Psychosomatics · doi:10.1159/000012395 · Cited by 478 · cited 3×
“Therefore, similar to several previous literature syntheses of mental health interventions across multiple conditions (12,18), a vote-counting approach (19) was used to classify each trial as positive or negative.”
BackgroundMethodSelf-citationPsychiatric Consultation in Somatization Disorder
Smith, G. R., Monson, R. A., & Ray, D. C. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605293142203 · Cited by 460
The difficult patient: Prevalence, psychopathology, and functional impairment
Hahn, S. R., Kroenke, K., Spitzer, R. L., Brody, D., Williams, J. B. W., Linzer, M., & deGruy, F. V. (1996) · Journal of General Internal Medicine · doi:10.1007/bf02603477 · Cited by 421
Self-citationCognitive-behavioral body image therapy for body dysmorphic disorder
Rosen, J. C., Reiter, J., & Orosan, P. (1995) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.63.2.263 · Cited by 384
Body dysmorphic disorder: A cognitive behavioural model and pilot randomised controlled trial
Veale, D., Gournay, K., Dryden, W., Boocock, A., Shah, F., Willson, R., & Walburn, J. (1996) · Behaviour Research and Therapy · doi:10.1016/0005-7967(96)00025-3 · Cited by 382
Kroenke, K. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830160080011 · Cited by 355
Self-citationSpeckens, A. E. M., van Hemert, A. M., Spinhoven, P., Hawton, K. E., Bolk, J. H., & Rooijmans, H. G. M. (1995) · BMJ · doi:10.1136/bmj.311.7016.1328 · Cited by 330
Antidepressant therapy for unexplained symptoms and symptom syndromes.
O’Malley, P. G., Jackson, J. L., Santoro, J., Tomkins, G., Balden, E., & Kroenke, K. (1999) · PubMed · Cited by 329
Self-citationDifficult Patient Encounters in the Ambulatory Clinic: Clinical Predictors and Outcomes
Jackson, J. L., & Kroenke, K. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.10.1069 · Cited by 328
Self-citationA Randomized Placebo-Controlled Trial of Fluoxetine in Body Dysmorphic Disorder
Phillips, K. A., Albertini, R. S., & Rasmussen, S. A. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.4.381 · Cited by 321
Cognitive Behavior Therapy for Hypochondriasis: A Randomized Controlled Trial
Barsky, A. J., & Ahern, D. K. (2004) · JAMA · doi:10.1001/jama.291.12.1464 · Cited by 307
Smith, G. R. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950150070012 · Cited by 305
Two psychological treatments for hypochondriasis: A randomised controlled trial
Clark, D. M., Salkovskis, P. M., Hackmann, A., Wells, A., Fennell, M., Ludgate, J., Ahmad, S., Richards, H. C., & Gelder, M. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.3.218 · Cited by 270
The difficult doctor-patient relationship: Somatization, personality and psychopathology
Hahn, S. R., Thompson, K. S., Wills, T. A., Stern, V., & Budner, N. S. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90212-7 · Cited by 270
A controlled trial of cognitive-behavioural treatment of hypochondriasis
Warwick, H. M. C., Clark, D. M., Cobb, A. M., & Salkovskis, P. M. (1996) · British Journal of Psychiatry · doi:10.1192/bjp.169.2.189 · Cited by 240 · cited 1×
“Of the 34 trials, 13 were conducted in the United States (20–24,28,29,33,36,39,47,51,53), 6 in Germany (27,30–32,41,42), 6 in the Netherlands (26,34,38,46,48,49), 4 in the United Kingdom (37,43,44,52), and 1 each in Denmark (40), Italy (45), Sri Lanka (25), Sweden (35), and Turkey (50).”
Physical Symptoms and Physician-Experienced Difficulty in the Physician–Patient Relationship
Hahn, S. R. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-9_part_2-200105011-00014 · Cited by 221
Cognitive-Behavioral Therapy for Somatization Disorder: A Randomized Controlled Trial
Allen, L. A., Woolfolk, R. L., Escobar, J. I., Gara, M. A., & Hamer, R. M. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.14.1512 · Cited by 209 · cited 2×
“Of the 22 trials involving an MHP-delivered intervention, 10 enrolled subjects solely or predominantly from primary care (22, 23 ,25,33,34,36,38,42,45,47), and the MHPs were psychiatrists in 16 trials (22,23,25,30–32,34,43–45,47–50,52,53), psychologists in 4 trials (38,42,46,51), and behavioral medicine specialists in…”
BackgroundBehavioral medicine approaches to somatoform disorders.
Looper, K. J., & Kirmayer, L. J. (2002) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.70.3.810 · Cited by 203
Smith, R. C., Lyles, J. S., Gardiner, J. C., Sirbu, C., Hodges, A., Collins, C., Dwamena, F. C., Lein, C., Given, C. W., Given, B., et al. (2006) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2006.00460.x · Cited by 187
Treatment of Functional Somatic Symptoms
(1995) · doi:10.1093/oso/9780192624994.001.0001 · Cited by 180
Psychosocial Treatments for Multiple Unexplained Physical Symptoms: A Review of the Literature
Allen, L. A., Escobar, J. I., Lehrer, P. M., Gara, M. A., & Woolfolk, R. L. (2002) · Psychosomatic Medicine · doi:10.1097/01.psy.0000024231.11538.8f · Cited by 180
Moene, F. C., Spinhoven, P., Hoogduin, K. A. L., & Dyck, R. V. (2003) · International Journal of Clinical and Experimental Hypnosis · doi:10.1076/iceh.51.1.29.14067 · Cited by 174
The treatment of hypochondriasis: exposure plus response prevention vs cognitive therapy
Visser, S., & Bouman, T. K. (2001) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(00)00022-x · Cited by 172
Kroenke, K., Taylor-Vaisey, A., Dietrich, A. J., & Oxman, T. E. (2000) · Psychosomatics · doi:10.1016/s0033-3182(00)71172-8 · Cited by 164
Self-citationMoene, F. C., Spinhoven, P., Hoogduin, K. A. L., & van Dyck, R. (2002) · Psychotherapy and Psychosomatics · doi:10.1159/000049348 · Cited by 164
A meta-analysis of psychological and pharmacological treatments for Body Dysmorphic Disorder
Williams, J., Hadjistavropoulos, T., & Sharpe, D. (2006) · Behaviour Research and Therapy · doi:10.1016/j.brat.2004.12.006 · Cited by 159
Revising the Classification of Somatoform Disorders: Key Questions and Preliminary Recommendations
Kroenke, K., Sharpe, M., & Sykes, R. (2007) · Psychosomatics · doi:10.1176/appi.psy.48.4.277 · Cited by 158
Self-citationHellman, C. J. C., Budd, M., Borysenko, J., McClelland, D. C., & Benson, H. (1990) · Behavioral Medicine · doi:10.1080/08964289.1990.9934605 · Cited by 155 · cited 1×
“Of the 22 trials involving an MHP-delivered intervention, 10 enrolled subjects solely or predominantly from primary care (22,23,25,33,34,36,38,42,45,47), and the MHPs were psychiatrists in 16 trials (22,23,25,30–32,34,43–45,47–50,52,53), psychologists in 4 trials (38,42,46,51), and behavioral medicine specialists in 2…”
BackgroundRaine, R., Haines, A., Sensky, T., Hutchings, A., Larkin, K., & Black, N. (2002) · BMJ · doi:10.1136/bmj.325.7372.1082 · Cited by 150
The outcome of physical symptoms with treatment of depression
Greco, T., Eckert, G., & Kroenke, K. (2004) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2004.30531.x · Cited by 145
Self-citationPsychosocial interventions for conversion disorder
Ruddy, R., & House, A. O. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005331.pub2 · Cited by 140
SUMATHIPALA, A., HEWEGE, S., HANWELLA, R., & MANN, A. H. (2000) · Psychological Medicine · doi:10.1017/s0033291799002160 · Cited by 129 · cited 3×
“Of the 34 trials, 13 were conducted in the United States (20–24,28,29,33,36,39,47,51,53), 6 in Germany (27,30–32,41,42), 6 in the Netherlands (26,34,38,46,48,49), 4 in the United Kingdom (37,43,44,52), and 1 each in Denmark (40), Italy (45), Sri Lanka (25), Sweden (35), and Turkey (50).”
BackgroundROST, K. M., Kashner, T. M., & Smith, G. R. (1994) · General Hospital Psychiatry · doi:10.1016/0163-8343(94)90113-9 · Cited by 123
Enhancing the Health of Somatization Disorder Patients
Kashner, T. M., ROST, K. M., Cohen, B., Anderson, M. L., & Smith, G. R. (1995) · Psychosomatics · doi:10.1016/s0033-3182(95)71627-9 · Cited by 122
Psychosocial interventions for somatizing patients by the general practitioner
Larisch, A., Schweickhardt, A., Wirsching, M., & Fritzsche, K. (2004) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2004.04.372 · Cited by 118
Lidbeck, J. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb09899.x · Cited by 118
Kroenke, K., & Rosmalen, J. G. M. (2006) · Medical Clinics of North America · doi:10.1016/j.mcna.2006.04.003 · Cited by 118
Self-citationAntidepressants and Cognitive-Behavioral Therapy for Symptom Syndromes
Jackson, J. L., O’Malley, P. G., & Kroenke, K. (2006) · CNS Spectrums · doi:10.1017/s1092852900014383 · Cited by 117
Self-citationNezu, A. M., Nezu, C. M., & Lombardo, E. R. (2001) · Behavior Therapy · doi:10.1016/s0005-7894(01)80035-6 · Cited by 114
Opipramol for the treatment of somatoform disorders results from a placebo-controlled trial
Volz, H., Möller, H., Reimann, I. W., & Stoll, K.-D. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00074-2 · Cited by 93
Rosendal, M., Olesen, F., Fink, P., Toft, T., Sokolowski, I., & Bro, F. (2007) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.03.005 · Cited by 91
Dickinson, W. P. (2003) · The Annals of Family Medicine · doi:10.1370/afm.5 · Cited by 90
Kroenke, K., Messina, N., Benattia, I., Graepel, J., & Musgnung, J. J. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0111 · Cited by 89
Self-citationRief, W., Martin, A., Rauh, E., Zech, T., & Bender, A. (2006) · Psychosomatics · doi:10.1176/appi.psy.47.4.304 · Cited by 86
Müller, T. H., Mannel, M., Murck, H., & Rahlfs, V. W. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000128900.13711.5b · Cited by 82
Paradoxical Therapy in Conversion Reaction
Ataoğlu, A., Özçetin, A., İçmeli, C., & Özbulut, Ö. (2003) · Journal of Korean Medical Science · doi:10.3346/jkms.2003.18.4.581 · Cited by 82
Martin, A., Rauh, E., Fichter, M., & Rief, W. (2007) · Psychosomatics · doi:10.1176/appi.psy.48.4.294 · Cited by 81 · cited 1×
“Of the 22 trials involving an MHP-delivered intervention, 10 enrolled subjects solely or predominantly from primary care (22,23,25,33,34,36,38,42,45,47), and the MHPs were psychiatrists in 16 trials (22,23,25,30–32,34,43–45,47–50,52,53), psychologists in 4 trials (38,42,46,51), and behavioral medicine specialists in 2…”
BackgroundSchilte, A. F., Portegijs, P. J. M., Blankenstein, A. H., van der Horst, H. E., Latour, M. B. F., van Eijk, J. T. M., & Knottnerus, J. A. (2001) · BMJ · doi:10.1136/bmj.323.7304.86 · Cited by 79
St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial
Volz, H., Murck, H., Kasper, S. F., & Möller, H. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1171-6 · Cited by 77
Explanatory Therapy in Hypochondriasis
Fava, G. A., Grandi, S., Rafanelli, C., Fabbri, S., & Cazzaro, M. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0414 · Cited by 73
Treatment of somatization in primary care
McLeod, C. C., Budd, M. A., & McClelland, D. C. (1997) · General Hospital Psychiatry · doi:10.1016/s0163-8343(97)00047-9 · Cited by 73 · cited 1×
“Of the 22 trials involving an MHP-delivered intervention, 10 enrolled subjects solely or predominantly from primary care (22,23,25,33,34,36,38,42,45,47), and the MHPs were psychiatrists in 16 trials (22,23,25,30–32,34,43–45,47–50,52,53), psychologists in 4 trials (38,42,46,51), and behavioral medicine specialists in 2…”
BackgroundMultiple medically unexplained physical symptoms and health care utilization
Kolk, A. M. M., Schagen, S. B., & Hanewald, G. J. F. P. (2004) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(04)00036-4 · Cited by 64
Peters, S., Stanley, I., Rose, M., Kaney, S., & Salmon, P. (2002) · Family Practice · doi:10.1093/fampra/19.6.665 · Cited by 49
Psychosocial interventions for conversion disorder
Ruddy, R., & House, A. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005331 · Cited by 32
Cited by
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
“The search of reference lists of 24 reviews or meta-analyses (Allen 2002; Atkinson 1985; Decoutere 2011; Escobar 1996; Fallon 2004; Fishbain 1998; Gildenberg 1984; Grothe 2004; Jackson 2000; Jackson 2006a; Jackson 2006b; Kroenke 2007; Lynch 2001; Magni 1991; Marks 2009; McQuay 1995; O’Malley 1999; Price 2000; Prior 20…”
BackgroundKroenke, K., Spitzer, R. L., Williams, J. B. W., & Löwe, B. (2010) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2010.03.006 · Cited by 4,057
“However, recent reviews have identified effective pharmacological and behavioral interventions [150–152].”
BackgroundSelf-citationThe Somatic Symptom Scale–8 (SSS-8): A Brief Measure of Somatic Symptom Burden
Gierk, B., Kohlmann, S., Kroenke, K., Spangenberg, L., Zenger, M., Brähler, E., & Löwe, B. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12179 · Cited by 740
Self-citationDepression, anxiety and somatization in primary care: Syndrome overlap and functional impairment
Löwe, B., Spitzer, R. L., Williams, J. B. W., Mussell, M., Schellberg, D., & Kroenke, K. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2008.01.001 · Cited by 706
“However, multiple studies [59–61] demonstrate that effective treatment of depression, anxiety and somatization improves functional status.”
BackgroundSelf-citationMind the gap: improving the dissemination of CBT
Shafran, R., Clark, D. M., Fairburn, C. G., Arntz, A., Barlow, D. H., Ehlers, A., Freeston, M., Garety, P. A., Hollon, S. D., Ost, L. G., et al. (2009) · Behaviour Research and Therapy · doi:10.1016/j.brat.2009.07.003 · Cited by 569
“(Kroenke, 2007) and schema-focused therapy and dialectical behaviour therapy are both effective for borderline personality disorder”
Background
Metadata
- Authors
- Kroenke, K.
- Affiliations
- Regenstrief Institute (US)
- Corresponding author
- Kroenke, Kurt
- ORCID
- Kroenke, Kurt
- Venue
- Psychosomatic Medicine
- Published
- 2007-11
- Volume
- 69
- Issue
- 9
- Pages
- 881-888
- ISSN
- 0033-3174 (ISSN-L)
- OpenAlex
- W2004606740
- Cited by
- 450
- References
- 68
- Citations by year
- 2026: 7 · 2025: 17 · 2024: 10 · 2023: 4 · 2022: 13 · 2021: 14 · 2020: 16 · 2019: 20 · 2018: 25 · 2017: 39 · 2016: 26 · 2015: 22 · 2014: 40 · 2013: 48 · 2012: 41
- FWCI
- 3.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychosomatic Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Keywords
- somatoform disorders, somatization disorder, medically unexplained symptoms, health anxiety, conversion disorder, pain disorders, body dysmorphic disorder, cognitive behavioral therapy, antidepressants, treatment efficacy
- MeSH terms
- Antidepressive Agents, Body Image, Combined Modality Therapy, Conversion Disorder, Delusions, Hypochondriasis, Primary Health Care, Somatoform Disorders, Cognitive Behavioral Therapy, Randomized Controlled Trials as Topic, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.